|
关注：1
2013-05-23 12:21
求翻译：To evaluate the clinical activity of MEDI4736 and tremelimumab administered as monotherapy and in combination to subjects with unresectable HCC using immune-related Response Evaluation Criteria in Solid Tumors (irRECIST) and modified Response Evaluation Criteria in Solid Tumors (mRECIST) for HCC.是什么意思？ 待解决
 悬赏分：1
- 离问题结束还有
To evaluate the clinical activity of MEDI4736 and tremelimumab administered as monotherapy and in combination to subjects with unresectable HCC using immune-related Response Evaluation Criteria in Solid Tumors (irRECIST) and modified Response Evaluation Criteria in Solid Tumors (mRECIST) for HCC.
问题补充： |
|
2013-05-23 12:21:38
正在翻译，请等待...
|
|
2013-05-23 12:23:18
评估临床活动, 皆4736 tremelimumab。它也是管理和组合与主题unresectable HCC使用免疫有关的反应评价标准,即固体肿瘤(irrecist)和修改响应评价标准,即固体肿瘤(mrecist)HCC。
|
|
2013-05-23 12:24:58
评估在组合和tremelimumab的执行的作为单独疗法和临床活动MEDI4736对主题与unresectable HCC使用与免疫相关的反应评估标准在坚实肿瘤 (irRECIST) 和修改过的反应评估标准在坚实肿瘤 (mRECIST) 为HCC。
|
|
2013-05-23 12:26:38
探讨肝癌 MEDI4736 和 tremelimumab 管理作为单一疗法和科目组合使用在实体肿瘤 (irRECIST) 免疫相关反应的评价标准和改性的反应固体肿瘤 (个) 中的评价标准不能手术切除肝癌的临床活动。
|
|
2013-05-23 12:28:18
正在翻译，请等待...
|
湖北省互联网违法和不良信息举报平台 | 网上有害信息举报专区 | 电信诈骗举报专区 | 涉历史虚无主义有害信息举报专区 | 涉企侵权举报专区
